Back to Results
First PageMeta Content
Endocrine system / Diabetes mellitus type 1 / Diabetes management / Insulin therapy / Novo Nordisk / Insulin / JDRF / Islets of Langerhans / Diabetes mellitus / Biology / Diabetes / Medicine


IMI2-GB-DEC[removed]Annex I 1st Call for Proposals 2014 Innovative Medicines Initiative 2 Version 3.3
Add to Reading List

Document Date: 2015-02-02 07:45:27

Open Document

File Size: 268,62 KB

Share Result on Facebook

City

Brussels / /

Company

Eli Lilly / Sanofi / Helmsley Charitable Trust / Novo Nordisk / /

Continent

Europe / /

Country

United States / /

Currency

EUR / /

/

IndustryTerm

THERAPY OF TYPE TO DISEASE / pharmaceutical industry / biomedical imaging / clinical trial network / electronic data capture devices / translational research network / bio-bank repositories / established clinical trial network / diverse clinical trials protocols / diagnostics solutions / cross functional data mining / pharmaceutical industry consortium / diabetes care / art technologies / medical information technology / implantable micro-devices / /

MedicalCondition

TRANSLATIONAL MODIFYING APPROACHES THERAPY OF TYPE TO DISEASE / dysfunction / obesity / metabolic disorders / pancreatic inflammation / insulin deficiency / T1DM disease / mostly adult diabetes / disease / increased disease / hyperglycemia / novel disease / diabetes / diabetes mellitus / autoimmune disease / diseases / human disease / manifest disease / /

MedicalTreatment

insulin therapy / immunosuppression / pharmacotherapy / /

Organization

T1DM Patient Advisory Committee / World Health Organization / Juvenile Diabetes Research Foundation / World Health Organisation / EFPIA / European Union / T1DM Advisory Committee / /

/

Position

coordinator / co-coordinator / /

Technology

art technologies / Proteomics / bioinformatics / antibodies / medical information technology / transplantation / drug discovery / Lab on a chip / diverse clinical trials protocols / data mining / SNP / Metabolomics / /

URL

http /

SocialTag